Q) In Regression of tumour after Neoadjuvant CTRT for rectal cancer are all except
A) Decrease in size
B) Nodal regression
C) Mucosal venous invasion in mri
D) Depth change
7000+ High-Yield MCQs & Explanations – NEET SS MCH
Q) In Regression of tumour after Neoadjuvant CTRT for rectal cancer are all except
A) Decrease in size
B) Nodal regression
C) Mucosal venous invasion in mri
D) Depth change
Q) All are true regarding perioperative management Of IBD on steroid except
a) Minor procedure needs only routine steroidal dose supplementation
b) Major procedures needs Hydrocort 100-150 mg tds
3.Chronic steroid use causing adrenal failure that presents with hypotension, vomiting, fever, lethargy
4.All cases of UC need supraphysiological dose of steroid.
Q) What is not true about extra levator Abdomino Perineal Resection (APE) (AIIMS 2019)
a) Anal canal dissected from levator
b) Patient in prone jack knife position
c) Specimen is resected en block with sacrum
d) Entire levator is resected along with mesorectum
Q) False regarding FAP
a) Mean age of development of cancer is 40
b)50% population develop gastric polyp and duodenal adenoma
c) 2nd most common cause of death is desmoid
d)
Q) False statement about management of cancer rectum
a) Relative to ERUS, pelvic MRI is more accurate in its ability to detect lymph node involvement
b) Rectal cancers located in the upper third of the rectum are exempt from neoadjuvant treatment.
c) TME is typically performed 2-3 weeks after completion of CRT before fibrosis develop
d) ERAS include early mobilization, transition to oral pain control, and resumption of oral food intake
A 12-year-old boy presents with recurrent episodes of painless rectal bleeding and anemia. Colonoscopy reveals multiple juvenile hamartomatous polyps throughout the colon. Which of the following statements regarding this syndrome is FALSE?
Get access to detailed explanations, clinical scenario-based MCQs, mock tests, image-based questions, and exam-focused surgery preparation resources.
Explore Premium MembershipAlready a member? Log in to access premium content.
Juvenile polyposis syndrome is an inherited gastrointestinal polyposis condition characterized by multiple juvenile hamartomatous polyps. Patients may present with rectal bleeding, anemia, abdominal symptoms, or complications related to polyp burden.
The principal genes associated with juvenile polyposis syndrome include SMAD4 and BMPR1A. The syndrome usually follows an autosomal dominant inheritance pattern.
JPS is associated with an increased risk of gastrointestinal malignancy, particularly colorectal cancer. Gastric cancer risk may also be increased. Appropriate surveillance and specialist assessment are important parts of management.
When a question describes a child with recurrent rectal bleeding and multiple juvenile hamartomatous polyps, consider juvenile polyposis syndrome. Remember the association with SMAD4 and BMPR1A, autosomal dominant inheritance, and increased gastrointestinal cancer risk.
Q: Which of the following is NOT a risk factor for pouchitis post-IPAA in ulcerative colitis?
Q ) Which of the following group of lymph nodes lymphatics of the colon first drain to?
a) Paracolic
b) Epicolic
c) Nodes along SMA/IMA
d) Para aortic
Q) All are true regarding complete mesorectal excision except
a) Introduced by Hobeninger
b) It is based on ligation of central artery
c) Increases yield of lymph nodes and has decreased recurrence
d) Line of resection is below Toldt's fasica